Literature DB >> 17660955

Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.

Tracy Cherlet1, Leigh C Murphy.   

Abstract

Breast tumorigenesis and breast cancer progression involves the deregulation or hyperactivation of intracellular signaling proteins that leads to uncontrolled cellular proliferation, invasion and metastasis. For example, the expression and cellular responses to estogen receptor (ER) and transforming growth factor beta (TGFbeta) signaling pathways change during breast tumorigenesis and breast cancer progression. While the expression and activity of ER and TGFbeta maybe significant in the development of breast cancer, alterations in the cross-talk between these pathways may be equally important. Autocrine and paracrine effects of TGFbeta on breast cancer cell growth have been known for some time, but only recently have direct interactions between ER and TGFbeta been described. The purpose of this article was to further characterize the cross-talk between ER and TGFbeta, by examining ER interaction with Smad3, a downstream mediator of TGFbeta signaling. Transient transfection of Cos1 cells with p3TP-lux, demonstrate that ERalpha and ERbeta(1) repress Smad3 transcriptional activity in an estradiol-dependent manner and that this effect is inhibited by antiestrogen treatment. The ERbeta variants, ERbeta(2) and ERbeta(5), did not have any effect on Smad3 transcriptional activity. Further experiments attempted to characterize the molecular mechanism by which activated ER inhibits Smad3 transcriptional activity. Results indicate that ligand-bound ER does not affect Smad3 protein expression levels and that ER does not form direct protein interactions with Smad3. Transient transfection of Cos1 cells with the Ap-1 transcription factor c-Jun but not c-Fos was able to rescue the inhibitory effect of estrogen on Smad3 transcriptional activity. Based on these results, a model is proposed whereby c-Jun is limiting in its ability to act as a Smad3 co-activator in the presence of E(2)-bound ER, possibly due to ER sequestering c-Jun away from the Smad3 responsive promoter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660955     DOI: 10.1007/s11010-007-9551-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  49 in total

1.  Altered expression of estrogen receptor coregulators during human breast tumorigenesis.

Authors:  L C Murphy; S L Simon; A Parkes; E Leygue; H Dotzlaw; L Snell; S Troup; A Adeyinka; P H Watson
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

2.  Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins.

Authors:  Y Yanagi; M Suzawa; M Kawabata; K Miyazono; J Yanagisawa; S Kato
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

3.  Physical and functional interaction of SMADs and p300/CBP.

Authors:  C Pouponnot; L Jayaraman; J Massagué
Journal:  J Biol Chem       Date:  1998-09-04       Impact factor: 5.157

4.  From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells.

Authors:  H Y Kang; H K Lin; Y C Hu; S Yeh; K E Huang; C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

5.  p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains.

Authors:  Y Kobayashi; T Kitamoto; Y Masuhiro; M Watanabe; T Kase; D Metzger; J Yanagisawa; S Kato
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

6.  Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue.

Authors:  E Leygue; H Dotzlaw; P H Watson; L C Murphy
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

7.  The effect of antiestrogens on TGF-beta-mediated chemotaxis of human breast cancer cells.

Authors:  Gina M Tong; Talitha T Rajah; Xiao Ping Zang; J Thomas Pento
Journal:  Anticancer Res       Date:  2002 Jan-Feb       Impact factor: 2.480

8.  Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.

Authors:  S M Gorsch; V A Memoli; T A Stukel; L I Gold; B A Arrick
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

9.  ERbeta1 and the ERbeta2 splice variant (ERbetacx/beta2) are expressed in distinct cell populations in the adult human testis.

Authors:  Philippa T K Saunders; Michael R Millar; Sheila Macpherson; D Stewart Irvine; Nigel P Groome; Lee R Evans; Richard M Sharpe; Graeme A Scobie
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

10.  Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer.

Authors:  L C Murphy; E Leygue; Y Niu; L Snell; S-M Ho; P H Watson
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

View more
  13 in total

1.  Control of transcriptional repression of the vitellogenin receptor gene in largemouth bass (Micropterus salmoides) by select estrogen receptors isotypes.

Authors:  Gustavo A Dominguez; Joseph H Bisesi; Kevin J Kroll; Nancy D Denslow; Tara Sabo-Attwood
Journal:  Toxicol Sci       Date:  2014-07-24       Impact factor: 4.849

2.  Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation.

Authors:  Ichiaki Ito; Aki Hanyu; Mitsutoshi Wayama; Natsuka Goto; Yoko Katsuno; Shohei Kawasaki; Yuka Nakajima; Masashi Kajiro; Yoko Komatsu; Akiko Fujimura; Ryuichi Hirota; Akiko Murayama; Keiji Kimura; Takeshi Imamura; Junn Yanagisawa
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

3.  A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue.

Authors:  Helga Bergholtz; Tonje Gulbrandsen Lien; Giske Ursin; Marit Muri Holmen; Åslaug Helland; Therese Sørlie; Vilde Drageset Haakensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-01-06       Impact factor: 2.673

Review 4.  Regulation of the human catalytic subunit of telomerase (hTERT).

Authors:  Michael Daniel; Gregory W Peek; Trygve O Tollefsbol
Journal:  Gene       Date:  2012-02-13       Impact factor: 3.688

5.  Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.

Authors:  Gregory W Peek; Trygve O Tollefsbol
Journal:  Exp Cell Res       Date:  2016-03-23       Impact factor: 3.905

Review 6.  Crosstalk of TGF-β and estrogen receptor signaling in breast cancer.

Authors:  Arja M Band; Marikki Laiho
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-11       Impact factor: 2.673

Review 7.  Cellular targets of estrogen signaling in regeneration of inner ear sensory epithelia.

Authors:  Jennifer S McCullar; Elizabeth C Oesterle
Journal:  Hear Res       Date:  2009-02-06       Impact factor: 3.208

8.  Estrogen modulates mesenchyme-epidermis interactions in the adult nipple.

Authors:  Hsing-Jung Wu; Ji Won Oh; Dan F Spandau; Sunil Tholpady; Jesus Diaz; Laura J Schroeder; Carlos D Offutt; Adam B Glick; Maksim V Plikus; Sachiko Koyama; John Foley
Journal:  Development       Date:  2017-03-13       Impact factor: 6.868

9.  Combinatorial PX-866 and Raloxifene Decrease Rb Phosphorylation, Cyclin E2 Transcription, and Proliferation of MCF-7 Breast Cancer Cells.

Authors:  Gregory W Peek; Trygve O Tollefsbol
Journal:  J Cell Biochem       Date:  2015-12-28       Impact factor: 4.429

10.  Association between Single Nucleotide Polymorphisms of SMAD3 and BMP5 with the Risk of Knee Osteoarthritis.

Authors:  Amar Chandra Sharma; Rajeshwar Nath Srivastava; Sudeepti Ratan Srivastava; Devendra Parmar; Ajai Singh; Saloni Raj
Journal:  J Clin Diagn Res       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.